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Abstract Urine pH is a useful marker for assessing
treatment need and efficacy in patients with nephrolithiasis.
Though the gold standard of measurement is with a pH
electrode, dipsticks offer the convenience of cost, ease of
use, and the possibility of patients measuring their own
values outside the clinic. The aim of this study was to
determine whether dipsticks offer the same accuracy as the
electrode. Paired measurements of freshly voided urine pH
with both electrode and dipstick were analysed in a mul-
tidisciplinary renal clinic. We found that although there
was a high Pearson correlation between the samples (0.89,
p = 0.001), urine dipstick measurements carried an
approximately 1 in 4 risk of producing clinically significant
differences (pH differences [ 0.5 pH unit) from meter
values. We also found that at high and low urine pH, the
dipstick tended to over- and underestimate true pH
readings, respectively. Examining the values in the 98
patients where a need for pharmacological urinary pH
manipulation was indicated by the true pH, we found 14
who would not have been appropriately treated, and 5 who
would have been unnecessarily medicated, if the stick pH
value had been used. We conclude that dipstick pH mea-
surement is insufficiently reliable for guiding clinical
decision-making.
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Introduction
Urine pH is a useful and easily measurable biochemical
marker. In the context of a kidney stone clinic, it can be
used to determine the need for urinary pH manipulation,
and also help monitor responses to treatment.
Urine pH may be measured in various ways. In the
outpatient setting, two are prevalent: dipstick testing and
use of a pH meter. The latter is regarded as the gold
standard [1], but is much less commonly employed than
dipstick testing. A number of factors make pH meter use
less attractive: first, such meters require regular calibration
with test solutions; second, user training is necessary; and
third, if samples are not tested when freshly voided, they
must be collected under oil, which can shorten the life of
the electrode. In contrast, dipsticks are single use test strips
that can measure a range of variables in addition to pH,
including presence of glucose, protein, leucocytes, and
nitrite. They require much less user training, and with the
advent of electronic readers, readings are less prone to
perception bias. For accuracy, however, the need for fresh
urine remains.
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Dipsticks are undoubtedly convenient and are therefore
in widespread clinical use for semi-quantitative detection
of haematuria, proteinuria, and glycosuria. For these pur-
poses, they are mostly sufficient for routine use, although
follow-up testing by another method such as microscopy or
blood testing may be required. In the urological context,
accurate pH determination of a fresh urine sample is useful
for proper management of the stone-forming patient. Our
clinical algorithm includes alkalinizing the urine to
pH C 6.5 in all but calcium phosphate and struvite stone
formers, where urine pH B 6.5 is sought; therefore, reli-
able pH readings are clinically important.
The relative accuracy of dipsticks in determining urinary
pH has not been determined. The aim of this study was to
compare dipstick measurement of urinary pH with gold
standard pH electrode readings.
Methods
Subjects and samples
Patients attending a regional metabolic renal clinic voided
fresh urine into sterile receptacles. Each sample was
immediately tested twice by a fully trained operator: once
with a calibrated urine pH meter (Mettler Toledo, Leices-
ter, UK) and again using Multistix urine dipsticks (Bayer).
An electronic reader (Clinitek, Bayer) was used to assess
dipstick findings. Samples were tested in random order.
Patients with renal tract calcification and/or nephrolithiasis
were evaluated biochemically, including 24-h quantifica-
tion of urinary calcium, oxalate, urate, citrate, amino-
acids, electrolytes and creatinine, and stone analysis where
possible.
Statistics
Paired dipstick and electrode measurements were corre-
lated using the Pearson coefficient, and discrete analysis
was used to further analyse the data. Absolute differences
were recorded between the electrode (as standard) and
dipstick (as variable) measurements. To evaluate effects on
clinical management, these differences were categorised as
\0.5 pH units, 0.51–1.0 pH unit, [1.01–1.5 pH units, and
[1.5 units. Since the dipstick reader gives results to 0.5
units, we also measured the spread of paired meter readings
associated with every 0.5 dipstick unit.
Results
390 urine samples from 214 patients were included in the
study. All patients attended the same regional metabolic
renal clinic over a 4-year period. All either (1) were known
to have a stone syndrome such as cystinuria; (2) were
recurrent stone formers; (3) had had a single episode of
nephrolithiasis under age 25; (4) had nephrocalcinosis on
renal imaging; (5) had a positive family history of neph-
rolithiasis; or (6) had another single-gene renal disorder
such as polycystic kidney disease; or a combination of
these.
Paired metered and dipstick pH readings were collected.
Figure 1 illustrates the readings obtained, which statisti-
cally correlated reasonably well (Pearson Correlation
Coefficient 0.89, p \ 0.001).
Table 1 shows that the majority of readings, 290/390 or
74.4 %, were acidic (B6.5 by meter), with the largest sub-
group (116/390, 29.7 %) yielding stick values of pH 5.
Examining absolute differences within pairs of measure-
ments statistically, we initially considered pH differences of
\0.5 units as clinically insignificant, since urine dipsticks
only measure in steps of 0.5 units. We found that in 286
cases (73.3 %) urine pH differences were not significant,
whereas in more than one in four (104/390), there was a
clinically significant error. This is subcategorised as follows:
95 samples displayed apparent differences between 0.5 and
1 pH unit (24.3 %), 7 between 1 and 1.5 pH units (1.7 %),
and on two occasions variation of 1.5–2 pH units was
recorded (0.51 %). No sample exhibited a difference greater
than 2 pH units. These data suggest that for every 4 dipstick
measurements made, one would produce a clinically sig-
nificant error, and that approximately one in 10 readings
would give a serious error of[1 pH unit difference.
At stick readings of [6.5, the true pH was likely to be
lower, and overall, this problem affected 220 (56.4 %) of
the recordings. Of these, 63 (16.2 % of total) were[0.5 pH
units. For stick pHs of 7.5 and above, all 48 (12.3 %) meter
readings demonstrated this overestimate. In contrast, at lower
Fig. 1 Scatter graph demonstrating range of electrode pH measure-
ments per stated dipstick pH measurement. Line of unity is dotted;
regression line is solid
130 Urolithiasis (2013) 41:129–132
123
stick pH values there was a high likelihood of underesti-
mating the true urine pH, accounting overall for 169
(43.3 %) of the errors, of which 41 (10.5 % of total) were
clinically significant. The spread of readings per dipstick
category lessened as pH rose, suggesting an increase in
perceived accuracy.
In 98 patients, a definite diagnosis was reached that
implied the need for pH alteration, comprising one or more of
hypercalciuria, calcium oxalate, urate or cystine stones, and
distal RTA. Among this group, there were 19 (19.3 %) where
the difference between stick and meter pHs would have led to
non-adherence to the algorithm. As displayed in Table 2, the
urine would not have been alkalinized had the dipstick
measurement been relied upon in 14 (14.3 %) of these (i.e.
the true pH was lower); in 4 (4.1 %) unnecessary alkalin-
ization would have been commenced (i.e dipstick suggested
urine pH \ 6.5 whereas meter pH was C6.5); and in one
patient (1 %), unnecessary attempts to acidify the urine
would likely have been made if only stick measurements
were available (Table 2). Importantly, the pH difference in
these patients was not always in excess of 0.5 units, under-
scoring the significance of accurate measurement.
Discussion
This study demonstrates that although the correlation
between two different modalities of urine pH measurement
is good by statistical criteria, clinically relevant discrepan-
cies occur with an unacceptable frequency. Approximately
one in four dipstick measurements yielded a clinically rel-
evant error, the majority of these being between 0.5 and
1 pH unit from the true urine pH value. This strongly sug-
gests that in a situation where patient management decisions
are guided by the result, particularly in the patient with
nephrolithiasis, dipsticks are not sufficiently accurate.
At stick pH readings \6, there was a bias towards
undervaluation compared with the meter. It can be seen
that although pH stick values of 6 had the closest mean
electrode reading (Table 1), this was rendered less useful
firstly by the wide range (Fig. 1), and secondly by the level
of overlap with the true values associated with stick mea-
surements of 5.5 and 6.5. At higher pH than this, there was
a likelihood of overestimation by dipstick. Since our target
pH value for treatment in all but calcium phosphate stone
formers is C6.5, clinically unwelcome sequelae of over-
estimation would, as outlined above and in Table 2, have
been the failure in initiation (or inappropriate withdrawal)
of alkalinizing agents, or unnecessary attempts to acidify
the urine of phosphate stone formers. Conversely, relying
on undervalued stick pH would have led us to treat a
subgroup of patients unnecessarily with urine alkalinizing
agents, which many patients find unpalatable at best, and
intolerable at worst. We recognize, however, that our
particular clinical algorithm may not be reflected in all
centres; thus, the potential management changes reported
here might differ elsewhere.
pH is an inverse function of log [H?], and so a pH
difference of only 0.1 means a 25 % increase in the con-
centration of H? ions. Thus, a difference of 0.5 is clinically
very relevant. However, although it is well recognized that
the determination of urine pH is clinically useful, caveats
apply. Firstly, fresh urine is required, since on exposure to
air, CO2 will leave the urine and pH will rise. Secondly, it
can be argued that dietary assessment should be added to
urinalysis, since human diets are usually acidic overall, and
this is borne out by our finding that almost 60 % of patients
had a pH B 6, a figure consistent with that found in the
general population.
Our data suggest that the higher the stick pH value, the
less accurate it becomes. A potential limitation of our
findings is that we used the single brand of dipstick
available in our clinical areas for measurement, and recent
work has shown that different brands of dipstick have
differing optimum pH, with some more accurate at lower
pH than others [1]. Since the majority of patients that we
see in the clinic appear to have acidic urine, it may be
appropriate to use a dipstick that is more sensitive to lower
pH levels, but this may have cost implications.
Reports of this kind are few; a study of vaginal pH
measurement also found a high Pearson co-efficient with
dipsticks but as with our study, wide discrepancies between
the electrode reference and dipsticks [2]. In the veterinary
world, a study concerning canine urinary pH again found
that urine dipsticks only had moderate agreement to a
variety of electrodes and could not be used for accurate
measurement [3].
The relative costs of using dipsticks compared to meter
measurements bear consideration, but are in fact similar.
Dipsticks are about £45 ? VAT for 100, and automated
dipstick readers about £750. This is of the order of a lab-
oratory grade pH meter suitable for clinical samples, plus








5 5.29 ± 0.32 0.29 ± 0.32 116
5.5 5.67 ± 0.44 0.17 ± 0.44 44
6 5.98 ± 0.34 0.01 ± 0.44 69
6.5 6.27 ± 0.32 0.23 ± 0.32 61
7 6.65 ± 0.26 0.45 ± 0.25 52
7.5 6.98 ± 0.16 0.52 ± 0.16 31
8 7.31 ± 0.22 0.69 ± 0.22 13
8.5 7.27 ± 0.4 1.23 ± 0.40 3
9 7.39 1.61 1
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replacement electrode and calibration fluids, the latter
being a recurring cost. Clearly, proper training of health
care personnel in either method is important.
The use of multisticks has already been found to confer
good negative predictive value for prevention of urinary
tract infections and for management of albuminuria in the
community setting [4, 5]. However, positive findings had to
be confirmed with laboratory testing. Urine pH is used in
the clinic as a guide to therapeutic strategy, particularly in
determining if alkalinization would be useful. To this end,
we considered possibilities of patients treating themselves
by modifying their therapy by home dipstick testing, as this
might be more cost-effective than quarterly/half yearly
reviews in clinic. One regime suggested by a study into
bladder cancer and pH is to take two measurements,
morning and evening [6]. Although in the outpatient setting
we are taking ‘‘snap-shots’’ of the urinary pH that are
dictated by the appointment time, and it is well known that
urinary pH rises during the day, unfortunately our findings
regarding dipsticks preclude the possibility of implement-
ing such a strategy with confidence for stone prevention.
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Table 2 Nineteen patients in whom urine pH-altering treatment would have differed without meter pH availability
Clinical indication Stick pH Meter pH Difference Consequence of stick
pH-based decision
100 % Calcium oxalate stones 6.5 5.68 -0.82 Undertreatment
91 % Calcium oxalate stones 6.5 6.15 -0.35 Undertreatment
87 % Calcium oxalate stones 6.5 6.14 -0.38 Undertreatment
66 % Calcium oxalate stones 6.5 5.82 -0.68 Undertreatment
60 % Calcium oxalate stones 6.5 5.93 -0.57 Undertreatment
Hypercalciuria, calcium oxalate stone 6.5 5.80 -0.7 Undertreatment
Hypercalciuria, previous stones 6 6.99 0.99 Overtreatment
Hypercalciuria, previous stones 6.5 6.14 -0.36 Undertreatment
Hypercalciuria, previous stones 6.5 6.15 -0.35 Undertreatment
Hypercalciuria, previous stones 6.5 5.95 -0.55 Undertreatment
Hypercalciuria, previous stones 6.5 6.17 -0.33 Undertreatment
Nephrocalcinosis 5.5 6.54 1.04 Overtreatment
MSK, previous stones 6 6.57 0.57 Overtreatment
MSK, previous stones 6.5 5.98 -0.52 Undertreatment
MSK, hypercalciuria 6.5 6.15 -0.35 Undertreatment
Cystinuria 6 6.50 0.5 Overtreatment
Cystinuria 6.5 6.24 -0.26 Undertreatment
Uric acid stones 7 6.41 -0.59 Undertreatment
Calcium phosphate stones 7 6.07 -1.07 Overtreatment
MSK medullary sponge kidney
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